BIOMAT Database Logo BIOMAT Database Logo

The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients. 2001

D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Napoli, Italy.

We studied the relationship between the HLA specificities associated with multiple sclerosis (MS) susceptibility in southern Italy and the reactivity of the human myelin basic protein (hMBP) immunogenic peptides 84-98 and 143-168, using short-term T-cell lines established from 9 MS patients and from 8 healthy individuals. In our population, DR15 was significantly associated with MS (34.9% in MS versus 13.7% in healthy controls, P < 0.05). This result is in agreement with the association found in northern Europe, but not with data obtained in a population from the island of Sardinia (Italy). In MS patients the frequency of reactive T-cell lines (TCL), tested for fine specificity against the immunodominant hMBP peptides 84-98 and 143-168, was increased for the hMBP 143-168 peptide (P < 0.05) but not for the 84-98 peptide. Although this reactivity was higher in DR15+ MS patients than in DR 15- MS patients, it seemed not to be associated with DR15 specificity in the MS population. Furthermore, there were no significant differences in frequency of reactive TCL to hMBP peptide 84-98 in DR15-positive or DR15-negative MS patients. Consequently, it appears that peptide 84-98, considered as a relevant autoantigen, is not implicated in the pathogenesis of MS in our population from southern Italy.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004676 Myelin Basic Protein An abundant cytosolic protein that plays a critical role in the structure of multilamellar myelin. Myelin basic protein binds to the cytosolic sides of myelin cell membranes and causes a tight adhesion between opposing cell membranes. Golli-MBP1 Protein,Golli-MBP2 Protein,HOG5 Protein,HOG7 Protein,MBP1 Protein,MBP2 Protein,MBP3 Protein,MBP4 Protein,Myelin Basic Protein, 17.2 kDa Isoform,Myelin Basic Protein, 18.5 kDa Isoform,Myelin Basic Protein, 20.2 kDa Isoform,Myelin Basic Protein, 21.5 kDa Isoform,Myelin Basic Protein, Isoform 1,Myelin Basic Protein, Isoform 2,Myelin Basic Protein, Isoform 3,Myelin Basic Protein, Isoform 4,Myelin Basic Protein, Isoform 5,Myelin Basic Protein, Isoform 6,Myelin Basic Protein, Isoform 7,Golli MBP1 Protein,Golli MBP2 Protein
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
July 1990, Journal of immunology (Baltimore, Md. : 1950),
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
Specificity of T lymphocyte lines for peptides of myelin basic protein.
July 1985, Journal of immunology (Baltimore, Md. : 1950),
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides.
May 1997, Journal of neuroimmunology,
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
Target epitopes of myelin basic protein specific T cell lines in multiple sclerosis.
March 1993, Italian journal of neurological sciences,
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein.
October 1996, Journal of neuroimmunology,
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis.
March 1989, Journal of neuroimmunology,
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
Human myelin basic protein (MBP) epitopes recognized by mouse MBP-selected T cell lines from multiple sclerosis patients.
January 1994, Journal of neuroimmunology,
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage.
September 1993, Annals of neurology,
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity.
September 1992, Annals of neurology,
D Montanaro, and V Sanna, and G Matarese, and B B Larby, and L Racioppi, and P B Carrieri, and R Bruno, and N J Davey, and S Zappacosta, and S Fontana
Human T-cell response to myelin basic protein in multiple sclerosis patients and healthy subjects.
January 1988, Journal of neuroscience research,
Copied contents to your clipboard!